tradingkey.logo
tradingkey.logo
Search

Hinge Health Inc

HNGE
Add to Watchlist
56.020USD
+1.010+1.84%
Close 05/08, 16:00ETQuotes delayed by 15 min
4.33BMarket Cap
LossP/E TTM

Hinge Health Inc

56.020
+1.010+1.84%
View Detailed Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+1.84%

5 Days

+23.31%

1 Month

+55.70%

6 Months

+25.92%

Year to Date

+20.60%

1 Year

0.00%

TradingKey Stock Score of Hinge Health Inc

Currency: USD Updated: 2026-05-08

Key Insights

Hinge Health Inc's fundamentals are relatively very healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 4 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 57.53.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Hinge Health Inc's Score

Industry at a Glance

Industry Ranking
4 / 75
Overall Ranking
49 / 4494
Industry
Healthcare Providers & Services

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Hinge Health Inc Highlights

StrengthsRisks
Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 100.82% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 587.86M.
Undervalued
The company’s latest PE is -7.21, at a low 3-year percentile range.
Held by Ron Baron
Star Investor Ron Baron holds 999.57K shares of this stock.

Analyst Rating

Based on 16 analysts
Buy
Current Rating
69.533
Target Price
+26.42%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Hinge Health Inc News

More news coming soon, stay tuned...

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

Hinge Health Inc Info

Hinge Health, Inc. leverages software, including artificial intelligence (AI), to largely automate care for joint and muscle health. The Company has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. It offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.
Ticker SymbolHNGE
CompanyHinge Health Inc
CEOPerez (Daniel Antonio)
Websitehttps://en-gb.hingehealth.com/
KeyAI